ORGANIZATION AND FUNCTIONS OF THE H-2 GENE COMPLEX
H-2 基因复合体的组织和功能
基本信息
- 批准号:3480700
- 负责人:
- 金额:$ 38.89万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:1976
- 资助国家:美国
- 起止时间:1976-01-01 至 1990-12-31
- 项目状态:已结题
- 来源:
- 关键词:B lymphocyte T lymphocyte chemical cleavage complement pathway gene expression genetic mapping genetic recombination genetic regulation glycosylation histocompatibility gene hormone regulation /control mechanism immunoregulation laboratory mouse macrophage major histocompatibility complex mixed tissue /cell culture monoclonal antibody mutant proteolysis
项目摘要
The murine H-2 major histocompatibility complex or MHC controls a diverse set of
products and traits whose definition is important to the understanding of
fundamental genetic and immunologic mechanisms, as well as to clinically
relevant research in transplantation and disease resistance. In the latter
context, H-2 is an important experimental model for the human MHC, the HLA gene
complex, because of their remarkable genetic and functional homology. The
long-term objective of this research is to resolve, by genetic, biochemical and
functional approaches, the multiple genes of the H-2 complex, in order to
advance our understanding of the organization, evolution and regulation of the
MHC genes. This research will focus particularly upon the genes of the internal
I and S regions of the H-2 complex, whose products mediate macrophage-T
lymphocyte-B lymphocyte regulatory interactions, and reactions of the complement
pathways, respectively. Two general approaches are to be taken: 1) Efforts
will be made to detect and characterize new mutations and recombinations, to
improve H-2 genetic fine structure mapping and to provide new and useful stocks
for further functional and biochemical studies. Progeny from mutagen-treated
parents will be screened by mixed leucocyte reactions and with monoclonal
antibodies to cellular alloantigens. Variants will be characterized
serologically, biochemically and functionally, with emphasis on improved
definition of the I-A, I-B, I-J, S and D regions. 2) The structure, synthesis
and processing of the S region C4 and Slp protein will be investigated, to
better define the genetic information that specifies their structures and the
genetic and hormonal regulatory mechanisms that control their expression.
Peptide mapping and amino acid sequence determinations will be done. The roles
of proteolytic cleavage and of glycosylation in processing of intracellular
precursors will be examined. Tissue sites of synthesis will be determined. C4
and Slp mRNA will be examined to probe regulatory mechanisms. Non-H-2 genes
regulating Slp expression will be further defined.
小鼠H-2主要组织相容性复合体或MHC控制着一系列不同的
产品和特征的定义对理解
基本的遗传和免疫学机制以及临床上
移植和抗病方面的相关研究。在后者中
背景,H-2是人类MHC--人类白细胞抗原基因的重要实验模型
复杂,因为它们在基因和功能上具有显著的同源性。这个
这项研究的长期目标是通过遗传、生化和
功能途径,即H-2复合体的多个基因,以便
增进我们对组织、演变和监管的理解
MHC基因。这项研究将特别集中在内部的基因
H-2复合体的I和S区,其产物介导巨噬细胞-T
淋巴细胞-B淋巴细胞的调节相互作用和补体反应
分别是路径。一般采取两种方法:1)努力
将被用于检测和表征新的突变和重组,以
改进H-2基因精细结构作图,提供新的有用种质
用于进一步的功能和生化研究。诱变剂处理的后代
父母将通过混合白细胞反应和单克隆性筛选
针对细胞同种异体抗原的抗体。变种将被描述为
从血清学、生化和功能上讲,重点是改善
I-A、I-B、I-J、S和D区的定义。2)结构、合成
并对S C4区和SLP蛋白的加工进行了研究
更好地定义指定其结构的遗传信息和
控制其表达的基因和激素调节机制。
将进行多肽图谱和氨基酸序列测定。角色
胞内加工中的蛋白水解性切割和糖基化
将对前兆进行审查。合成的组织部位将被确定。C4
并将检测SLP基因的表达,以探讨其调控机制。非H-2基因
对SLP表达的调控将进一步明确。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
DONALD C. SHREFFLER其他文献
DONALD C. SHREFFLER的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('DONALD C. SHREFFLER', 18)}}的其他基金
TRAINING PROGRAM IN IMMUNOLOGY AND IMMUNOGENETICS
免疫学和免疫遗传学培训计划
- 批准号:
3530911 - 财政年份:1978
- 资助金额:
$ 38.89万 - 项目类别:
SUPPLEMENT TRAINING PROGRAM IN IMMUNOLOGY AND IMMUNOGENE
免疫学和免疫原补充培训计划
- 批准号:
3530910 - 财政年份:1978
- 资助金额:
$ 38.89万 - 项目类别:
TRAINING PROGRAM IN IMMUNOLOGY AND IMMUNOGENETICS
免疫学和免疫遗传学培训计划
- 批准号:
3530912 - 财政年份:1978
- 资助金额:
$ 38.89万 - 项目类别:
TRAINING PROGRAM IN IMMUNOLOGY AND IMMUNOGENETICS
免疫学和免疫遗传学培训计划
- 批准号:
3530913 - 财政年份:1978
- 资助金额:
$ 38.89万 - 项目类别:
ORGANIZATION AND FUNCTIONS OF THE H-2 GENE COMPLEX
H-2 基因复合体的组织和功能
- 批准号:
3125271 - 财政年份:1976
- 资助金额:
$ 38.89万 - 项目类别:
ORGANIZATION AND FUNCTIONS OF THE H-2 GENE COMPLEX
H-2 基因复合体的组织和功能
- 批准号:
3480699 - 财政年份:1976
- 资助金额:
$ 38.89万 - 项目类别:
ORGANIZATION AND FUNCTIONS OF THE H-2 GENE COMPLEX
H-2 基因复合体的组织和功能
- 批准号:
3480697 - 财政年份:1976
- 资助金额:
$ 38.89万 - 项目类别:
相似海外基金
Modulation of T lymphocyte Activation by Ã2-Adrenergic Receptor Signalling Pathways
α2-肾上腺素能受体信号通路对 T 淋巴细胞激活的调节
- 批准号:
RGPIN-2019-06980 - 财政年份:2022
- 资助金额:
$ 38.89万 - 项目类别:
Discovery Grants Program - Individual
A precision tumor neoantigen identification pipeline for cytotoxic T-lymphocyte-based cancer immunotherapies
用于基于细胞毒性 T 淋巴细胞的癌症免疫疗法的精准肿瘤新抗原识别流程
- 批准号:
10581488 - 财政年份:2022
- 资助金额:
$ 38.89万 - 项目类别:
Modulation of T lymphocyte Activation by ß2-adrenergic Receptor Signalling Pathways
α2-肾上腺素能受体信号通路对 T 淋巴细胞激活的调节
- 批准号:
574979-2022 - 财政年份:2022
- 资助金额:
$ 38.89万 - 项目类别:
University Undergraduate Student Research Awards
A precision tumor neoantigen identification pipeline for cytotoxic T-lymphocyte-based cancer immunotherapies
用于基于细胞毒性 T 淋巴细胞的癌症免疫疗法的精准肿瘤新抗原识别流程
- 批准号:
10332251 - 财政年份:2022
- 资助金额:
$ 38.89万 - 项目类别:
Modulation of T lymphocyte Activation by Ã2-adrenergic Receptor Signalling Pathways
α2-肾上腺素能受体信号通路对 T 淋巴细胞激活的调节
- 批准号:
574984-2022 - 财政年份:2022
- 资助金额:
$ 38.89万 - 项目类别:
University Undergraduate Student Research Awards
Modulation of T lymphocyte Activation by ß2-adrenergic Receptor Signalling Pathways
α2-肾上腺素能受体信号通路对 T 淋巴细胞激活的调节
- 批准号:
574985-2022 - 财政年份:2022
- 资助金额:
$ 38.89万 - 项目类别:
University Undergraduate Student Research Awards
Modulation of T lymphocyte Activation by Ã2-adrenergic Receptor Signalling Pathways
α2-肾上腺素能受体信号通路对 T 淋巴细胞激活的调节
- 批准号:
574978-2022 - 财政年份:2022
- 资助金额:
$ 38.89万 - 项目类别:
University Undergraduate Student Research Awards
Investigating the cell-based activity of a new class of cytotoxic T-lymphocyte antigen-4 (CTLA-4) small molecule inhibitors
研究一类新型细胞毒性 T 淋巴细胞抗原 4 (CTLA-4) 小分子抑制剂的细胞活性
- 批准号:
444149 - 财政年份:2021
- 资助金额:
$ 38.89万 - 项目类别:
Operating Grants
Novel pathways in T lymphocyte differentiation and function
T 淋巴细胞分化和功能的新途径
- 批准号:
RGPIN-2015-05491 - 财政年份:2021
- 资助金额:
$ 38.89万 - 项目类别:
Discovery Grants Program - Individual
Modulation of T lymphocyte Activation by ß2-Adrenergic Receptor Signalling Pathways
通过 α2-肾上腺素能受体信号通路调节 T 淋巴细胞激活
- 批准号:
RGPIN-2019-06980 - 财政年份:2021
- 资助金额:
$ 38.89万 - 项目类别:
Discovery Grants Program - Individual